BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35963905)

  • 1. Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms.
    Liu JB; Cai J; Dhir M; Paniccia A; Zureikat AH; Ramonell KM; McCoy KL; Carty SE; Yip L
    Ann Surg Oncol; 2022 Nov; 29(12):7808-7817. PubMed ID: 35963905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
    Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
    Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.
    Niederle B; Selberherr A; Bartsch DK; Brandi ML; Doherty GM; Falconi M; Goudet P; Halfdanarson TR; Ito T; Jensen RT; Larghi A; Lee L; Öberg K; Pavel M; Perren A; Sadowski SM; Tonelli F; Triponez F; Valk GD; O'Toole D; Scott-Coombes D; Thakker RV; Thompson GB; Treglia G; Wiedenmann B
    Neuroendocrinology; 2021; 111(7):609-630. PubMed ID: 32971521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
    van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
    Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
    Nell S; Verkooijen HM; Pieterman CRC; de Herder WW; Hermus AR; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Ann Surg; 2018 Jun; 267(6):1155-1160. PubMed ID: 28257328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
    Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
    Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
    Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
    Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
    Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
    Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis.
    Konukiewitz B; Enosawa T; Klöppel G
    Virchows Arch; 2011 Jan; 458(1):47-53. PubMed ID: 20922407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
    Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
    Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias.
    Albers MB; Almquist M; Bergenfelz A; Nordenström E
    Langenbecks Arch Surg; 2020 Mar; 405(2):137-143. PubMed ID: 32291468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.